Jonathan Rees

CEO at MitoRx Therapeutics

Presenter

Jon Rees has served as Chief Executive Officer of MitoRx since founding the Company in 2021. He brings more than 20 years of experience across biotech, venture capital, pharma and life sciences strategy. Prior to MitoRx, Jon advised and supported emerging biotechnology companies on financing, business development and investor engagement, contributing to many successful financing rounds. He was instrumental in securing the first venture investment for Ducentis BioTherapeutics, which was subsequently acquired in a deal valued at up to $400 million.

Previously, Jon served as CEO of BioUK (OBN), the UK’s leading life sciences membership organization, transforming it into a financially sustainable and influential network supporting hundreds of innovative companies. He also established BioTrinity as one of Europe’s leading life sciences investment conferences and helped drive significant sector fundraising and growth initiatives. Jon has held roles with Takeda Rare Diseases, Life Science Partners (LSP), and several advisory and investor relations organizations in the life sciences ecosystem. He serves as a Trustee of PKD Charity UK.

Jon completed postdoctoral research in metabolic engineering at the University of Oxford and holds a PhD from Royal Holloway, University of London.